ClinicalTrials.Veeva

Menu

NAVISCORE PMCF Study ( rEPIC04F )

F

Fundación EPIC

Status

Completed

Conditions

Ischemic Heart Disease
Coronary Artery Disease

Treatments

Device: Naviscore

Study type

Observational

Funder types

Other

Identifiers

NCT05706805
NAVISCORE PMCF Study

Details and patient eligibility

About

Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Naviscore scoring balloon to meet EU Medical Device regulation (MDR) requirements in all the CONSECUTIVE patients treated with Naviscore.

Full description

The objective of this multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study is to confirm and support the clinical safety and performance of the Naviscore scoring balloon in a NON-SELECTED, Real World population under daily clinical practice when used as intended by the manufacturer to meet EU Medical Device regulation requirements for post-market clinical follow-up.

Enrollment

54 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient treated with Naviscore according to routine hospital practice and following instructions for use
  • Informed consent signed

Exclusion criteria

• Not meet inclusion criteria

Trial design

54 participants in 1 patient group

Coronary Artery Disease (CAD)
Treatment:
Device: Naviscore

Trial contacts and locations

7

Loading...

Central trial contact

FUNDACION EPIC; FUNDACION EPIC

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems